Novel enantiomers and diastereoisomers structurally related to σ ligand (+)-MR200 were synthesized to improve σ(1)/σ(2) subtype selectivity. The selective σ(1) ligand (-)-8 showed an antagonist profile determined by phenytoin differential modulation of binding affinity in vitro, confirmed in vivo by an increase of κ opioid analgesia. The σ(2) ligand (-)-9 displayed agonist properties in an in vitro isolated organ bath assay and antiproliferative effects on LNCaP and PC3 prostate cancer cell lines.
Novel potent and selective σ ligands: evaluation of their agonist and antagonist properties
MARRAZZO, Agostino;PARENTI, Carmela;RONSISVALLE, SIMONE;PASQUINUCCI, Lorella Giuseppina;PREZZAVENTO, Orazio;SCOTO, Giovanna Maria;RONSISVALLE, Giuseppe
2011-01-01
Abstract
Novel enantiomers and diastereoisomers structurally related to σ ligand (+)-MR200 were synthesized to improve σ(1)/σ(2) subtype selectivity. The selective σ(1) ligand (-)-8 showed an antagonist profile determined by phenytoin differential modulation of binding affinity in vitro, confirmed in vivo by an increase of κ opioid analgesia. The σ(2) ligand (-)-9 displayed agonist properties in an in vitro isolated organ bath assay and antiproliferative effects on LNCaP and PC3 prostate cancer cell lines.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Marrazzo 2011-2.pdf
solo gestori archivio
Licenza:
Non specificato
Dimensione
697.55 kB
Formato
Adobe PDF
|
697.55 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
